Laura Carzaniga

This inventor holds 12 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 13 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Carzaniga. Retrieved from https://idiyas.com/inventor/laura-carzaniga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 10)

% Patents Active = 66.7

CIPO Patents = 2 (Patent Applications = 13)

EPO Patents = 13 (Patent Applications = 18)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

12 out of 341

Chiesi Farmaceutici S.p.a.

patents

Years Active: 2015-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723052 - Tetrahydrothieno pyridine derivatives as DDRs inhibitors (2026-09-01),

2. 12617801 - Tetrahydrothieno pyridine derivatives as DDRS inhibitors (2026-05-05),

3. 10196386 - Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity (2019-02-05),

4. 10004728 - Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity (2018-06-26),

5. 9944612 - 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors (2018-04-17),

6. 9932338 - Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity (2018-04-03),

7. 9931327 - Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors (2018-04-03),

8. 9662323 - Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity (2017-05-30),

9. 9579314 - Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity (2017-02-28),

10. 9440954 - Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors (2016-09-13),

11. 9321776 - Isochromene derivatives as phoshoinositide 3-kinases inhibitors (2016-04-26),

12. 9024027 - Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors (2015-05-05),

Title: Laura Carzaniga: Innovator in Pharmaceutical Science

Introduction

Laura Carzaniga is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target specific receptors in the body. With a total of 10 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents are innovative compounds that exhibit both muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity. These compounds are defined by specific formulas and are designed to be useful in the prevention and treatment of broncho-obstructive or inflammatory diseases. The dual action of these compounds makes them particularly valuable in addressing complex medical conditions.

Career Highlights

Laura Carzaniga is currently employed at Chiesi Farmaceutici S.p.A., a company known for its commitment to developing innovative pharmaceutical solutions. Her work at Chiesi has allowed her to focus on creating effective treatments that can improve patient outcomes.

Collaborations

Throughout her career, Laura has collaborated with notable colleagues, including Fabio Rancati and Andrea Rizzi. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Laura Carzaniga's contributions to pharmaceutical science through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in the treatment of respiratory and inflammatory diseases.

Profile summary based on public USPTO records.